Evidence map›Paper›PMID 36678763›Full record

ArticlePharmaceutics2022

Composite Nanoarchitectonics of Photoactivated Titania-Based Materials with Anticancer Properties.

Nefeli Papadopoulou-Fermeli, Nefeli Lagopati, Natassa Pippa, Elias Sakellis, Nikos Boukos, Vassilis G Gorgoulis, Maria Gazouli, Evangelia A Pavlatou

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Biocompatible PANI-Encapsulated Chemically Modified Nano-TiONanomaterials (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Nefeli Papadopoulou-FermeliLaboratory of General Chemistry, School of Chemical Engineering, National Technical University of Athens, Zografou Campus, 15789 Zografou, Greece.
Nefeli LagopatiLaboratory of General Chemistry, School of Chemical Engineering, National Technical University of Athens, Zografou Campus, 15789 Zografou, Greece.
Natassa PippaSection of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Athens, Greece.
Elias SakellisInstitute of Nanoscience and Nanotechnology, National Center for Scientific Research "Demokritos", 15310 Agia Paraskevi, Greece.ORCID 0000-0002-2361-3382
Nikos BoukosInstitute of Nanoscience and Nanotechnology, National Center for Scientific Research "Demokritos", 15310 Agia Paraskevi, Greece.ORCID 0000-0001-7542-0649
Vassilis G GorgoulisLaboratory of Histology-Embryology, Molecular Carcinogenesis Group, Department of Basic Medical Sciences, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0001-9001-4112
Maria GazouliLaboratory of Biology, Department of Basic Medical Sciences, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-3295-6811
Evangelia A PavlatouLaboratory of General Chemistry, School of Chemical Engineering, National Technical University of Athens, Zografou Campus, 15789 Zografou, Greece.
National Technical University of Athens · GRNational and Kapodistrian University of Athens · GRNational Centre of Scientific Research "Demokritos" · GRUniversity of Dundee · GB

Funding

Hellenic Foundation for Research and Innovation HFRI Grant No. 2436
6 · The paper itself

Abstract

The synthesis of titania-based composite materials with anticancer potential under visible-light irradiation is the aim of this study. In specific, titanium dioxide (TiO

Indexed as

Ag-TiO2anticancer activitycomposite materialsmicrogelnanoarchitectonicsphotocatalysisPNIPAMsol-gelvisible light

Identifiers

PMID36678763
PMCPMC9864881
OpenAlexW4313473070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.